| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming …
Over the last 12 months, insiders at Xtant Medical Holdings, Inc. have bought $0 and sold $0 worth of Xtant Medical Holdings, Inc. stock.
On average, over the past 5 years, insiders at Xtant Medical Holdings, Inc. have bought $568,485 and sold $2.43M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 41,670 shares for transaction amount of $49,837 was made by Brandt Kevin D (Chief Commercial Officer) on 2023‑11‑17.
| 2025-04-10 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 17.11M 11.3567% | $0.42 | $7.19M | +65.92% | |
| 2023-11-17 | Brandt Kevin D | Chief Commercial Officer | 41,670 0.0341% | $1.20 | $49,837 | -32.20% | ||
| 2023-01-18 | Sale | Neils Scott C | Chief Financial Officer | 8,673 0.0082% | $0.61 | $5,283 | +55.51% | |
| 2022-10-19 | Sale | Browne Sean E | President and CEO | 51,100 0.0471% | $0.62 | $31,820 | +9.68% | |
| 2022-10-18 | Sale | Browne Sean E | President and CEO | 80,000 0.0763% | $0.68 | $54,008 | +4.62% | |
| 2022-10-07 | Vizirgianakis Stavros G. | director | 2.26M 1.4161% | $0.48 | $1.09M | -3.55% | ||
| 2022-08-15 | Sale | Brandt Kevin D | Chief Commercial Officer | 18,700 0.0162% | $0.49 | $9,172 | +26.88% | |
| 2022-08-15 | Sale | Neils Scott C | Chief Financial Officer | 1,270 0.0011% | $0.48 | $605 | +26.88% | |
| 2018-02-14 | Rizzo Matthew | 945,819 1.3083% | $7.20 | $6.81M | +15.06% | |||
| 2018-02-14 | ORBIMED ADVISORS LLC | 945,819 1.3083% | $7.20 | $6.81M | +15.06% | |||
| 2018-02-14 | Eggenberg Michael | 945,819 1.3083% | $7.20 | $6.81M | +15.06% | |||
| 2016-05-09 | Goldberger Daniel S | Chief Executive Officer | 5,000 0.0004% | $2.34 | $11,700 | -64.89% | ||
| 2015-12-03 | Swanson Kent L | director | 2,300 0.0002% | $2.82 | $6,493 | -27.05% | ||
| 2015-12-01 | Swanson Kent L | director | 1,000 <0.0001% | $2.85 | $2,850 | -28.07% | ||
| 2015-11-20 | Kirschman David Louis | EVP & Chief Scientific Officer | 2,000 0.0002% | $2.99 | $5,983 | -28.23% | ||
| 2015-11-20 | Swanson Kent L | director | 4,976 0.0004% | $3.00 | $14,928 | -28.23% | ||
| 2015-11-19 | Kirschman David Louis | EVP & Chief Scientific Officer | 1,000 <0.0001% | $2.94 | $2,943 | -29.19% | ||
| 2015-11-19 | Swanson Kent L | director | 24 <0.0001% | $2.90 | $70 | -29.19% | ||
| 2015-11-18 | Kirschman David Louis | EVP & Chief Scientific Officer | 1,000 <0.0001% | $2.86 | $2,862 | -27.24% | ||
| 2015-11-16 | Goldberger Daniel S | Chief Executive Officer | 3,000 0.0002% | $2.80 | $8,400 | -20.45% |
| Rizzo Matthew | 5890884 4.1991% | $1.64M | 1 | 0 | +15.06% | |
| Eggenberg Michael | 5890884 4.1991% | $1.64M | 1 | 0 | +15.06% | |
| Vizirgianakis Stavros G. | director | 5850716 4.1705% | $1.63M | 1 | 0 | <0.0001% |
| Kirschman David Louis | EVP & Chief Scientific Officer | 1701063 1.2126% | $472,895.51 | 3 | 0 | <0.0001% |
| COOK GUY S | 10 percent owner | 1200000 0.8554% | $333,600.00 | 18 | 31 | <0.0001% |
| Brandt Kevin D | Chief Commercial Officer | 815860 0.5816% | $226,809.08 | 1 | 1 | <0.0001% |
| Goldberger Daniel S | Chief Executive Officer | 86522 0.0617% | $24,053.12 | 8 | 0 | <0.0001% |
| Swanson Kent L | director | 83128 0.0593% | $23,109.58 | 8 | 0 | <0.0001% |
| JUDA GREGORY ALEXANDER | Chief Scientific Officer | 40000 0.0285% | $11,120.00 | 2 | 0 | <0.0001% |
| WICKWIRE JON M. | director | 31247 0.0223% | $8,686.67 | 4 | 0 | |
| DEEDRICK JOHN ARTHUR | director | 16621 0.0118% | $4,620.64 | 1 | 0 | |
| LOPACH MICHAEL A | director | 14258 0.0102% | $3,963.72 | 2 | 0 | |
| GANDOLFO JOHN P | CFO | 9943 0.0071% | $2,764.15 | 1 | 0 | |
| ORBIMED ADVISORS LLC | 10 percent owner | 0 0% | $0 | 1 | 1 | +15.06% |
| Increased Positions | 16 | +38.1% | 2M | +2.04% |
| Decreased Positions | 16 | -38.1% | 292,775 | -0.37% |
| New Positions | 12 | New | 1M | New |
| Sold Out Positions | 7 | Sold Out | 91,953 | Sold Out |
| Total Postitions | 42 | 0% | 81M | +1.67% |
| Nantahala Capital Management, Llc | $51,090.00 | 48.85% | 68.39M | 0 | 0% | 2025-09-30 |
| Awm Investment Company, Inc. | $4,926.00 | 4.71% | 6.59M | -2,500 | -0.04% | 2025-09-30 |
| Vanguard Group Inc | $1,760.00 | 1.68% | 2.36M | +104,159 | +4.63% | 2025-09-30 |
| Renaissance Technologies Llc | $533.00 | 0.51% | 713,915 | +63,205 | +9.71% | 2025-09-30 |
| Geode Capital Management, Llc | $367.00 | 0.35% | 491,949 | -61,675 | -11.14% | 2025-09-30 |
| Crescent Grove Advisors, Llc | $308.00 | 0.29% | 412,024 | 0 | 0% | 2025-09-30 |
| Millennium Management Llc | $181.00 | 0.17% | 242,924 | -19,575 | -7.46% | 2025-09-30 |
| Bridgeway Capital Management, Llc | $123.00 | 0.12% | 164,100 | 0 | 0% | 2025-09-30 |
| Private Advisor Group, Llc | $92.00 | 0.09% | 123,000 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $90.00 | 0.09% | 120,326 | 0 | 0% | 2025-09-30 |